M. Michelle Berrey - 14 Dec 2022 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
President, R&D and CMO
Signature
/s/ Rocco Venezia, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
14 Dec 2022
Net transactions value
-$18,615
Form type
4
Filing time
16 Dec 2022, 15:01:53 UTC
Previous filing
16 Sep 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $18,615 -1,246 -1.8% $14.94 69,942 14 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.